Q2i empowers healthcare teams with leading edge technology to improve the success of their Medication-Assisted Treatment (MAT) program.
Q2i’s solutions comprise healthcare team portals and patient mobile applications. We provide decision support software through data-rich, patient-centric, unified dashboards. Our technology includes predictive analytics (including AI and ML), telehealth and reward based solutions that increase patient engagement, adherence to treatment plans, connectedness and support, resulting in:
- Focus on at-risk patients
Outliers identified and patients managed by exception
- Timely interventions
Trending issues immediately flagged for attention
- Better outcomes
Improved ownership and adherence to treatment plans
100% Cloud, ready-to-go
Start using Q2i to support your program in minutes – easily setup and manage your clinic and patients.
Modern User Interface
The Q2i healthcare team portal and patient app interface is intuitive and easy to navigate for an unequalled user experience.
Q2i customizable branding allows you to integrate Q2i into your digital tool box and keeps your branding message consistent.
Flexible and Scalable
Q2i can be used as a stand alone program management solution or easily integrated with your existing EHR.
Q2i is proud to be HIPAA compliant. All data policies are designed to meet or exceed HIPAA’s requirements.
Opioid Addiction Recovery Support is used by providers of MAT programs to improve insight into a patient’s recovery progress and promotes ownership and adherence to treatment plans. OARS also provides extensive tools to support patients with recovery from Opioid Use Disorder. Using OARS patients are better connected to, and supported by their healthcare team throughout their recovery journey.
This extended connection and support fosters conditions for:
Continuing Alumni Support Application provides ongoing connection and support to patients who have completed a residential or Intensive Out Patient recovery program.
CASA enables providers to regularly deliver educational and motivational content including reinforcement of relapse prevention strategies direct to the CASA powered mobile app.
The peer-to-peer messaging component helps build and maintain a network of sober friends with other alumni of the clinic and stay connected to others who relate to similar experiences and challenges.
The Bari-Well solution supports bariatric healthcare teams and their patients by enhancing a bariatric program’s connectivity, efficiency and success.
Bari-Well empowers bariatric programs to better manage their patient populations. Bari-Well supports patients with pre and post surgery treatment plans in order to successfully achieve goals of long-term weight-loss.
Bari-Well provides useful tools to help providers manage and support their patients throughout all stages of the continuum of care.
To design, develop, and supply the most advanced technologies that empower healthcare teams to improve the success rate of their Medication-Assisted Treatment (MAT) programs.
To drive innovation, thereby increasing MAT program availability and access so that all Americans seeking recovery from Opioid Use Disorder can obtain the treatment they need.
Q2i collaborates with multidisciplinary healthcare teams, providers and payers to understand and then realize unmet technology needs. We facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams.
Q2i develops technology that assists health care providers in achieving the IHI quadruple aim of improving the patient experience of care (including quality and satisfaction), improving the health of populations, reducing the per capita cost of health care and improved clinician experience.
Steven Jenkins has over 20 years of senior management experience in the technology and HealthTech sectors in North America and Europe. Prior to founding Q2i, he worked for 10 years on medical technologies (devices and software applications) that aided pediatric pain and anxiety management and improved home dialysis. He is focused on launching medical technologies that improve patient outcomes and reduce clinical costs.
Gerald A. Kraines, M.D.
Gerald A. Kraines, M.D. a faculty member at Harvard Medical School for over 30 years, Dr. Kraines received an undergraduate degree from Oberlin College in organic chemistry, a medical degree from Case Western Reserve, and a psychiatric fellowship and a postgraduate degree in community psychiatry from HarvardMedical School. Dr. Kraines has undertaken several public health projects in the United States, including two years in the U.S. Public Health Service.
Tony McNamara has over 15 years of experience driving innovation in medical technology companies. He was involved in the first wave of Electronic Medical Record and of Case Management Systems, including both ConnectMD and Phycom’s CarePartner. His experience with medical devices includes portable ultrasound (BladderScanner), tele-medicine-enabled video (laryngoscope),and carrying the Olympic Medical Cerebral Function Monitor from mid-stream to completion.
Director, Grants and Strategic Partnerships
Monica has over 20 years of experience in fundraising, strategic planning, managing strategic partnerships, and coordinating fundraising programs. Her focusis on grants administration (pre-award development and post-award compliance), supporting organizations with the development and submission of federal, foundation and industry-sponsored grant proposals.
Medical Advisory Board
Q2i’s Medical Advisory Board provides in-depth subject matter expertise across a broad spectrum of healthcare delivery. This diverse composition provides a strong group dynamic providing insight and scientific direction. This ensures Q2i’s solutions not only improves patient outcomes and helps health systems and payers create value but that we go beyond traditional clinical efficacy to capture newer patient-focused considerations and impact the effectiveness and efficiency of care delivered under new value-based performance systems.
Sara M. Bolton
Dr. Bolton is an assistant clinical professor of psychiatry at Harvard Medical School and an associate psychiatrist at McLean Hospital.
Dr. Chinman is assistant professor of psychiatry at Harvard Medical School and president-elect of the Massachusetts Psychiatric Society.
PT, MSPT, OCS, Cert. MDT
Jeremy is a faculty member in the Department of Kinesiology and is the Director of the Nayden Rehabilitation Clinic.
MD, MHA, FSCAI
Dr. Jennifer Davenport is a Medical Director and Director of Interventional Cardiology. She has a Masters in Health Systems Administration and Policy.
Q2i in the News
Please check back with us for upcoming events and conference details or contact us.
1660 Soldiers Field Rd.
Brighton, MA 02135